Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
21/05/202406:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202406:18Edgar (US Regulatory)Form 8-K - Current reportAMEX:AIRIAir Industries Group
21/05/202406:17PR Newswire (US)Ascent Strategy Group, the first agency founded to fuel the Digital Health revolution, introduces the industry's first communications tools to guide healthcare's transformation
21/05/202406:16PR Newswire (US)VANTIS VASCULAR SECURES $5 MILLION IN SAFE FINANCING TO DRIVE INNOVATION IN VASCULAR INTERVENTIONS
21/05/202406:16PR Newswire (US)New Omdia research states that cellular IoT data traffic will comprise 4.2% of total cellular data traffic in 2028
21/05/202406:15GlobeNewswire Inc.Blackrock Silver Announces $9 Million Bought Deal Public Offering of Units, Led by Investment from Eric SprottTSXV:BRCBlackrock Silver Corp
21/05/202406:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ASAmer Sports Inc
21/05/202406:15Business WireAll Three Leading Independent Proxy Advisory Firms Support All Xperi Board CandidatesNYSE:XPERXperi Inc
21/05/202406:15PR Newswire (US)OneOncology's Treatment Pathways Certified by ASCO
21/05/202406:15PR Newswire (US)First Batch of Green Energy Buses with Yuchai Xingshunda Hydrogen Fuel Cells LaunchedNYSE:CYDChina Yuchai International Ltd
21/05/202406:15PR Newswire (US)Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE®NASDAQ:HALOHalozyme Therapeutics Incorporated
21/05/202406:15PR Newswire (US)Introducing the Bridge: Flair's New Dedicated Plug-and-Play Networking Gateway
21/05/202406:15PR Newswire (US)Ancoris Recognised as Top Place to Work for Second Year Running by The Sunday Times
21/05/202406:13Edgar (US Regulatory)Form N-30B-2 - Periodic and interim reports mailed to shareholdersNYSE:EICCEagle Point Income Company Inc
21/05/202406:13IH Market NewsU.S. Index Futures Open Lower Amid Nasdaq Record, Fed SpeechesNASDAQ:VSATViaSat Inc
21/05/202406:12Alliance NewsAlliance NewsCOMMODITIES MARKET: Oil and gold ease on US interest rate concerns
21/05/202406:11CointelegraphBitcoin shorts worth $1.4B at risks of liquidation if BTC price hits $74.3KCOIN:BTCUSDBitcoin
21/05/202406:11Alliance NewsAlliance NewsPowerhouse shares surge on "significant milestone" patent winLSE:PHEPowerhouse Energy Group Plc
21/05/202406:11PR Newswire (US)New Autobiography Details Harsh Experiences of Fleeing Iraq and the Ensuing Torture
21/05/202406:10GlobeNewswire Inc.Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession LicenseTG:M2QCarbon Streaming Corporation
21/05/202406:07Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNYSE:KRKroger Co
21/05/202406:07GlobeNewswire Inc.Stellantis to Participate in Bernstein 40th Annual Strategic Decisions ConferenceSTLA.PA
21/05/202406:07Business WireEDITION eröffnet sein 20. Hotel in Dschidda und markiert ein neues Zeitalter für das Königreich Saudi-ArabienNASDAQ:MARMarriott International Inc
21/05/202406:06Business WireAdvyzon Investment Management (AIM) Adds New Asset Managers, Including BlackRock and DFA
21/05/202406:06Business WireeDreams ODIGEO Recognized by Forbes as One of the 'Best Companies to Work for 2024' for Third Consecutive Year
21/05/202406:05Business WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
21/05/202406:05Business WireAnumana Demonstrates Global Readiness with Receipt of ISO 13485 Certification
21/05/202406:05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
21/05/202406:05GlobeNewswire Inc.Xtract One Announces Fiscal 2024 Third Quarter Conference Call0PL
21/05/202406:05Business WireDelphinus Medical Technologies Announces New VP of Engineering